A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
06 2020
Historique:
received: 04 12 2019
revised: 24 02 2020
accepted: 02 03 2020
pubmed: 21 4 2020
medline: 14 4 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

Severe hypercholesterolemia (HC, LDL-C > 4.9 mmol/L) affects over 30 million people worldwide. In this study, we validated a new polygenic risk score (PRS) for LDL-C. Summary statistics from the Global Lipid Genome Consortium and genotype data from two large populations were used. A 36-SNP PRS was generated using data for 2,197 white Americans. In a replication cohort of 4,787 Finns, the PRS was strongly associated with the LDL-C trait and explained 8% of its variability (p = 10 The new PRS has a better predictive role in identifying HC of polygenic origin compared to the currently available method and can better stratify patients into diagnostic and therapeutic algorithms.

Sections du résumé

BACKGROUND
Severe hypercholesterolemia (HC, LDL-C > 4.9 mmol/L) affects over 30 million people worldwide. In this study, we validated a new polygenic risk score (PRS) for LDL-C.
METHODS
Summary statistics from the Global Lipid Genome Consortium and genotype data from two large populations were used.
RESULTS
A 36-SNP PRS was generated using data for 2,197 white Americans. In a replication cohort of 4,787 Finns, the PRS was strongly associated with the LDL-C trait and explained 8% of its variability (p = 10
CONCLUSION
The new PRS has a better predictive role in identifying HC of polygenic origin compared to the currently available method and can better stratify patients into diagnostic and therapeutic algorithms.

Identifiants

pubmed: 32307928
doi: 10.1002/mgg3.1248
pmc: PMC7284038
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1248

Subventions

Organisme : NIMH NIH HHS
ID : RL1 MH083268
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004610
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004608
Pays : United States
Organisme : Medical Research Council
ID : MR/M013138/2
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG004609
Pays : United States
Organisme : Wellcome Trust
ID : WT/104955/Z/14/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL087679
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004424
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004438
Pays : United States
Organisme : Medical Research Council
ID : MR/M013138/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH063706
Pays : United States

Informations de copyright

© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.

Références

Hypertension. 2004 Dec;44(6):838-46
pubmed: 15520301
Proc Biol Sci. 2015 Dec 22;282(1821):20151684
pubmed: 26702037
Mol Genet Genomic Med. 2020 Jun;8(6):e1248
pubmed: 32307928
Genet Epidemiol. 2015 Sep;39(6):439-45
pubmed: 26198599
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Clin Chem. 2015 Jan;61(1):231-8
pubmed: 25414277
Nat Genet. 2009 Jan;41(1):35-46
pubmed: 19060910
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Atherosclerosis. 2017 Aug;263:405-411
pubmed: 28549500
Trends Genet. 2019 May;35(5):371-382
pubmed: 30922659
Nat Rev Cardiol. 2019 Jan;16(1):9-20
pubmed: 29973710
Nat Commun. 2018 Aug 23;9(1):3391
pubmed: 30140000
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
BMC Med Genomics. 2011 Jan 26;4:13
pubmed: 21269473
Atherosclerosis. 2019 Feb;281:207-212
pubmed: 30458964
J Am Coll Cardiol. 2014 May 20;63(19):1935-47
pubmed: 24632267
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Lancet. 2013 Apr 13;381(9874):1293-301
pubmed: 23433573
Curr Cardiol Rep. 2017 May;19(5):44
pubmed: 28405938
Int J Mol Med. 2013 Mar;31(3):577-82
pubmed: 23314909
Curr Opin Lipidol. 2018 Apr;29(2):133-143
pubmed: 29300201
Hum Mutat. 2017 Mar;38(3):289-296
pubmed: 27957775
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Curr Cardiol Rep. 2019 Apr 22;21(6):43
pubmed: 31011892
Atherosclerosis. 2018 Oct;277:457-463
pubmed: 30270085

Auteurs

Luis G Leal (LG)

Department of Life Sciences, Centre for Integrative Systems Biology and Bioinformatics, Imperial College London, London, United Kingdom.

Clive Hoggart (C)

Department of Medicine, Imperial College London, London, United Kingdom.

Marjo-Riitta Jarvelin (MR)

Faculty of Medicine, Center for Life Course Health Research, University of Oulu, Oulu, Finland.
Biocenter Oulu, University of Oulu, Oulu, Finland.
Unit of Primary Health Care, Oulu University Hospital, Oulu, Finland.
Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Middlesex, United Kingdom.

Karl-Heinz Herzig (KH)

Biocenter Oulu, University of Oulu, Oulu, Finland.
Research Unit of Biomedicine, Oulu University, Oulu, Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.
Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, Poznan, Poland.

Michael J E Sternberg (MJE)

Department of Life Sciences, Centre for Integrative Systems Biology and Bioinformatics, Imperial College London, London, United Kingdom.

Alessia David (A)

Department of Life Sciences, Centre for Integrative Systems Biology and Bioinformatics, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH